Changes in oral antidiabetic prescriptions and improved glycemic control during the years 2002–2011 in <scp>J</scp>apan (<scp>JDDM</scp>32)

The OAD prescribing trend has moved away from monotherapy with SUs and toward combination therapies to achieve better glycemic control. Increased use of BGs and DPP-4I was predominant in 2011. These trends were accompanied by an improvement of the glycated hemoglobin level.